1.84
price down icon0.54%   -0.01
after-market After Hours: 1.84
loading
Seer Inc stock is traded at $1.84, with a volume of 207.75K. It is down -0.54% in the last 24 hours and up +5.14% over the past month. Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
See More
Previous Close:
$1.85
Open:
$1.87
24h Volume:
207.75K
Relative Volume:
0.85
Market Cap:
$103.50M
Revenue:
$14.18M
Net Income/Loss:
$-82.66M
P/E Ratio:
-1.4154
EPS:
-1.3
Net Cash Flow:
$-50.80M
1W Performance:
-11.54%
1M Performance:
+5.14%
6M Performance:
-12.38%
1Y Performance:
-9.80%
1-Day Range:
Value
$1.825
$1.8796
1-Week Range:
Value
$1.67
$1.90
52-Week Range:
Value
$1.62
$2.41

Seer Inc Stock (SEER) Company Profile

Name
Name
Seer Inc
Name
Phone
650-453-0000
Name
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Name
Employee
134
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
SEER's Discussions on Twitter

Compare SEER vs VRTX, REGN, ARGX, ALNY, ONC

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SEER
Seer Inc
1.84 104.07M 14.18M -82.66M -50.80M -1.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.82 121.40B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
764.93 83.25B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
728.11 46.39B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.51 43.41B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
292.94 33.09B 5.36B 287.73M 924.18M 2.5229

Seer Inc Stock (SEER) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-05-23 Resumed JP Morgan Neutral
Jan-04-23 Downgrade BofA Securities Neutral → Underperform
Aug-11-22 Downgrade JP Morgan Overweight → Neutral
Oct-15-21 Resumed Cowen Outperform
Dec-29-20 Initiated BofA Securities Neutral
Dec-29-20 Initiated Cowen Outperform
Dec-29-20 Initiated JP Morgan Overweight
Dec-29-20 Initiated Morgan Stanley Equal-Weight
View All

Seer Inc Stock (SEER) Latest News

pulisher
09:28 AM

Decliners Report: Can Seer Inc deliver consistent EPS growth2025 Trading Volume Trends & Consistent Profit Focused Trading Strategies - baoquankhu1.vn

09:28 AM
pulisher
02:18 AM

Sectors Review: Can Seer Inc be recession proof2025 Price Momentum & Weekly High Momentum Picks - baoquankhu1.vn

02:18 AM
pulisher
Mar 04, 2026

Aug Volume: What is the target price for Seer Inc stockEarnings Beat & Community Shared Stock Ideas - baoquankhu1.vn

Mar 04, 2026
pulisher
Mar 04, 2026

SEER: Strong growth, innovation, and new detector tech set the stage for future expansion - TradingView

Mar 04, 2026
pulisher
Mar 04, 2026

Bradley Radoff Sends Open Letter to Seer, Inc. - marketscreener.com

Mar 04, 2026
pulisher
Mar 04, 2026

Seer (SEER) Stockholders Express Concerns Over Management and Fi - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

Incorrect alert on Seer Inc's forecast withdrawn - marketscreener.com

Mar 04, 2026
pulisher
Mar 04, 2026

Radoff-Jec Group calls on Seer board to announce sale process - marketscreener.com

Mar 04, 2026
pulisher
Mar 04, 2026

The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs - Stock Titan

Mar 04, 2026
pulisher
Mar 03, 2026

SEER Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026
pulisher
Mar 02, 2026

Activist group in Seer (SEER) reports 7.6% stake and opposes NOL pill - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Seer (NASDAQ: SEER) expands Proteograph platform and targets $30B proteomics market - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Seer 10-K: Revenue $16.58M, EPS $(1.28) - TradingView

Mar 02, 2026
pulisher
Mar 01, 2026

Seer Inc. Balances Growth Momentum With Cautious Outlook - TipRanks

Mar 01, 2026
pulisher
Feb 28, 2026

Seer, Inc. (NASDAQ:SEER) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 28, 2026
pulisher
Feb 27, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Feb 27, 2026
pulisher
Feb 27, 2026

Seer Q4 Earnings Call Highlights - Yahoo Finance

Feb 27, 2026
pulisher
Feb 27, 2026

SEER Should I Buy - Intellectia AI

Feb 27, 2026
pulisher
Feb 27, 2026

Seer, Inc. (NASDAQ:SEER) Short Interest Up 126.6% in February - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Seer Inc (SEER) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Funding Challenges - GuruFocus

Feb 27, 2026
pulisher
Feb 27, 2026

SEER Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 27, 2026
pulisher
Feb 27, 2026

Seer, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SEER) 2026-02-27 - Seeking Alpha

Feb 27, 2026
pulisher
Feb 26, 2026

Seer (SEER) Q4 2025 Earnings Call Transcript - AOL.com

Feb 26, 2026
pulisher
Feb 26, 2026

Seer Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Seer Adopts Tax Benefit Plan to Protect NOLs - TipRanks

Feb 26, 2026
pulisher
Feb 26, 2026

Seer Inc. (NASDAQ:SEER) Shares Plunge on Weak 2026 Revenue Guidance - ChartMill

Feb 26, 2026
pulisher
Feb 26, 2026

SEER: 2025 revenue rose 17% to $16.6M, but 2026 growth is tempered by funding headwinds - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Seer (NASDAQ:SEER) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Earnings call transcript: Seer Inc. reports Q4 2025 earnings beat, stock dips - Investing.com Australia

Feb 26, 2026
pulisher
Feb 26, 2026

SEER: 2025 revenue rose 17% to $16.6M, but 2026 guidance remains cautious amid funding uncertainty - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Q4 2025 Seer Inc Earnings Call Transcript - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

Seer Q4 Earnings Summary & Key Takeaways - Benzinga

Feb 26, 2026
pulisher
Feb 26, 2026

Seer, Inc. Adopts Tax Benefit Preservation Plan to Protect Income Tax Net Operating Losses - Quiver Quantitative

Feb 26, 2026
pulisher
Feb 26, 2026

Seer (SEER) sets 4.9% tax benefit rights plan with $11 exercise price - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

SEER: 2025 revenue rose 17% year-over-year, with improved margins and a strong liquidity position - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

[8-K] Seer, Inc. Reports Material Event | SEER SEC FilingForm 8-K - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Seer moves to shield $262M tax breaks by discouraging big holders - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

Seer, Inc. Provides Revenue Guidance for the Full Year 2026 - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Seer (SEER) Earnings Date and Reports 2026 - MarketBeat

Feb 26, 2026
pulisher
Feb 25, 2026

What To Expect From Seer Inc (SEER) Q4 2025 Earnings - GuruFocus

Feb 25, 2026
pulisher
Feb 24, 2026

Seer Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView

Feb 24, 2026
pulisher
Feb 23, 2026

Radoff-JEC Group Issues Open Letter to Seer Inc.?s Board of Directors - marketscreener.com

Feb 23, 2026
pulisher
Feb 23, 2026

The Radoff-JEC Group Issues Open Letter to Seer Inc.'s Board of Directors Regarding the Immediate Need for Significant Change - Investing News Network

Feb 23, 2026
pulisher
Feb 23, 2026

Seer (SEER) Investors Demand Immediate Governance Changes - GuruFocus

Feb 23, 2026
pulisher
Feb 23, 2026

Radoff-Jec Group recently sent an open letter to the board of directors of Seer, Inc., emphasizing the urgent need for significant strategic adjustments at the company. - Bitget

Feb 23, 2026
pulisher
Feb 23, 2026

User - The Chronicle-Journal

Feb 23, 2026
pulisher
Feb 20, 2026

Earnings Preview: Seer Inc to Report Financial Results Post-market on February 26 - 富途牛牛

Feb 20, 2026
pulisher
Feb 20, 2026

Activist group takes 6.5% Seer (SEER) stake and pushes strategic review - Stock Titan

Feb 20, 2026
pulisher
Feb 20, 2026

Wall Street Recap: Is Rallybio Corporation subject to activist investor interestNew Guidance & Smart Investment Allocation Tips - baoquankhu1.vn

Feb 20, 2026

Seer Inc Stock (SEER) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Seer Inc Stock (SEER) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Farokhzad Omid
CEO AND CHAIR
Feb 18 '26
Sale
1.99
24,385
48,646
3,349,064
Horn David R.
PRESIDENT & CFO
Nov 19 '25
Sale
1.97
6,797
13,400
436,802
Farokhzad Omid
CEO AND CHAIR
Nov 19 '25
Sale
1.97
33,838
66,708
1,238,230
Horn David R.
PRESIDENT & CFO
Aug 20 '25
Sale
2.04
6,827
13,955
436,802
Farokhzad Omid
CEO AND CHAIR
Aug 20 '25
Sale
2.04
33,992
69,483
1,272,068
Nishar Dipchand
Director
Jun 13 '25
Sale
2.08
30,253
62,935
49,204
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
Cap:     |  Volume (24h):